PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
800.81%
Revenue growth exceeding 1.5x Insurance - Life median of 1.98%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
800.81%
Gross profit growth exceeding 1.5x Insurance - Life median of 2.28%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
42.89%
EBIT growth of 42.89% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
42.89%
Positive operating income growth while Insurance - Life is negative. Peter Lynch would spot a big relative advantage here.
-0.15%
Negative net income growth while Insurance - Life median is -8.37%. Seth Klarman would investigate factors dragging net income down.
-0.17%
Negative EPS growth while Insurance - Life median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-0.17%
Negative diluted EPS growth while Insurance - Life median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-77.27%
Negative OCF growth while Insurance - Life median is 1.46%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-77.27%
Negative FCF growth while Insurance - Life median is 4.70%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
-20.01%
Negative 10Y revenue/share CAGR while Insurance - Life median is 0.55%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
-48.99%
Negative 5Y CAGR while Insurance - Life median is 12.41%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-12.07%
Negative 3Y CAGR while Insurance - Life median is 2.27%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
-55.21%
Negative 10Y OCF/share CAGR while Insurance - Life median is 0.26%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-78.20%
Negative 5Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-70.17%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
-13.03%
Negative 10Y net income/share CAGR vs. Insurance - Life median of 0.00%. Seth Klarman might see a fundamental problem if peers maintain growth.
168.43%
5Y net income/share CAGR > 1.5x Insurance - Life median of 23.97%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
385.46%
3Y net income/share CAGR > 1.5x Insurance - Life median of 1.72%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
72.65%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 28.29% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
55.51%
5Y equity/share CAGR > 1.5x Insurance - Life median of 27.96%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
65.57%
3Y equity/share CAGR > 1.5x Insurance - Life median of 13.38%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.45%
AR growth of 3.45% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
3.56%
Asset growth of 3.56% while Insurance - Life median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
5.72%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
-15.50%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-3.00%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.